Patients with the rs1799971 AG genotype may have a decreased analgesic response to oxycodone as compared to patients with the AA genotype. However, another study failed to find an association. This drug-variant pair has been assigned a 鈥渘o recommendation鈥?by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect response to oxycodone.